Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cholangiocarcinoma × Association × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Myelodysplastic Syndromes 2 Leukemia, Myeloid, Acute 2 Sarcoma, Kaposi 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Leukemia, Prolymphocytic 1 Leukemia, Plasma Cell 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Hematologic Diseases 1 Cholangiocarcinoma 1 Burkitt Lymphoma 1

Interventions

Gemcitabine 97 Cisplatin 64 Oxaliplatin 40 pembrolizumab 31 Fluorouracil 30 Capecitabine 30 durvalumab 26 lenvatinib 24 Leucovorin 24 Radiofrequency Ablation 11 Nivolumab 11 Magnetic Resonance Spectroscopy 11 Irinotecan 11 Drug Therapy 11 apatinib 10 Radiotherapy 10 Albumin-Bound Paclitaxel 10 pemigatinib 9 Taxes 9 tislelizumab 8 Specimen Handling 8 Folfox protocol 8 Floxuridine 8 Biopsy 8 Bevacizumab 8 130-nm albumin-bound paclitaxel 8 tremelimumab 7 Liver Transplantation 7 Cholangiopancreatography, Endoscopic Retrograde 7 Carboplatin 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01912053 2018-05-11

MispheC

Center Eugene Marquis

Phase 2 Completed

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡